Vestal Point Capital, LP Tyra Biosciences, Inc. Transaction History
Vestal Point Capital, LP
- $1.4 Trillion
- Q1 2025
A detailed history of Vestal Point Capital, LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 2,879,829 shares of TYRA stock, worth $28 Million. This represents 1.91% of its overall portfolio holdings.
Number of Shares
2,879,829
Previous 990,000
190.89%
Holding current value
$28 Million
Previous $13.8 Billion
94.63%
% of portfolio
1.91%
Previous 0.82%
Shares
2 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.5MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$104 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$40.3 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$39.7 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$39.5 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$39.5 Million8.77% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $408M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...